CAS 1832576-04-1

Formule : C16H14ClF3N6O2

InChI : InChI=1S/C16H14ClF3N6O2/c1-8(28-2)14-10(7-22-13-6-12(17)25-26(13)14)24-15(27)23-9-3-4-21-11(5-9)16(18,19)20/h3-8H,1-2H3,(H2,21,23,24,27)/t8-/m0/s1

Code InChI : ZMPUACZRXUZAJD-QMMMGPOBSA-N

SMILES : C[C@@H](C1=C(C=NC2=CC(=NN21)Cl)NC(=O)NC3=CC(=NC=C3)C(F)(F)F)OC

MLT-943

CAS : 1832576-04-1

Ref: IN-DA0027FS

MLT-943

CAS : 1832576-04-1

MLT-943

Formule : C₁₆H₁₄ClF₃N₆O₂

Degré de pureté : ≥98%

Masse moléculaire : 414.77

Ref: 54-BUP12237

MLT-943

CAS : 1832576-04-1

MLT-943 is a potent, selective and orally active MALT1 protease inhibitor. [1].

Formule : C₁₆H₁₄ClF₃N₆O₂

Degré de pureté : 99.72% - 99.82%

Couleur et forme : White Solid

Masse moléculaire : 414.77

Ref: TM-T9216

MLT-943

CAS : 1832576-04-1

MLT-943 is a potent medicinal compound that has been shown to inhibit the growth of cancer cells. It works by inducing apoptosis, or programmed cell death, in tumor cells. MLT-943 is an analog of a protein kinase inhibitor found in Chinese medicinal plants. This compound has been shown to be effective against various types of cancer in both human and animal models. MLT-943 inhibits the activity of kinases involved in cell division, which ultimately leads to the death of cancer cells. This compound has also been shown to have anti-cancer effects when administered orally or intravenously. Additionally, MLT-943 can be detected in urine using luciferase assays, making it a promising candidate for further development as an anticancer drug.

Formule : C₁₆H₁₄ClF₃N₆O₂

Degré de pureté : Min. 95%

Masse moléculaire : 414.77 g/mol

Ref: 3D-HYC57604